Sartorius Stedim Biotech SA (DIM) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.044x

Based on the latest financial reports, Sartorius Stedim Biotech SA (DIM) has a cash flow conversion efficiency ratio of 0.044x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€182.60 Million ≈ $213.48 Million USD) by net assets (€4.14 Billion ≈ $4.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sartorius Stedim Biotech SA (DIM) defensive interval to measure how many days the company can operate on defensive assets alone.

Sartorius Stedim Biotech SA - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Sartorius Stedim Biotech SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sartorius Stedim Biotech SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sartorius Stedim Biotech SA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
VAT Group AG
SW:VACN
0.133x
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
0.123x
Fabrinet
NYSE:FN
0.050x
Roku Inc
NASDAQ:ROKU
0.075x
Inner Mongolia BaoTou Steel Union Co Ltd
SHG:600010
0.009x
Hua Nan Financial Holdings Co Ltd
TW:2880
0.125x
Hua Xia Bank Co Ltd
SHG:600015
-0.089x
Bank of Ireland Group PLC
IR:BIRG
-0.021x

Annual Cash Flow Conversion Efficiency for Sartorius Stedim Biotech SA (2005–2025)

The table below shows the annual cash flow conversion efficiency of Sartorius Stedim Biotech SA from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see DIM market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €4.13 Billion
≈ $4.82 Billion
€538.60 Million
≈ $629.68 Million
0.131x -35.56%
2024-12-31 €4.02 Billion
≈ $4.70 Billion
€815.10 Million
≈ $952.94 Million
0.203x -27.45%
2023-12-31 €2.67 Billion
≈ $3.13 Billion
€746.40 Million
≈ $872.62 Million
0.279x +14.65%
2022-12-31 €2.51 Billion
≈ $2.94 Billion
€612.30 Million
≈ $715.84 Million
0.244x -39.35%
2021-12-31 €1.73 Billion
≈ $2.03 Billion
€695.97 Million
≈ $813.66 Million
0.402x +42.84%
2020-12-31 €1.48 Billion
≈ $1.73 Billion
€416.88 Million
≈ $487.38 Million
0.281x +6.75%
2019-12-31 €1.18 Billion
≈ $1.38 Billion
€310.13 Million
≈ $362.57 Million
0.263x +21.07%
2018-12-31 €1.04 Billion
≈ $1.22 Billion
€227.29 Million
≈ $265.72 Million
0.218x +9.51%
2017-12-31 €879.45 Million
≈ $1.03 Billion
€174.69 Million
≈ $204.23 Million
0.199x -3.19%
2016-12-31 €763.56 Million
≈ $892.68 Million
€156.66 Million
≈ $183.15 Million
0.205x -7.00%
2015-12-31 €647.22 Million
≈ $756.67 Million
€142.79 Million
≈ $166.94 Million
0.221x +6.73%
2014-12-31 €538.51 Million
≈ $629.58 Million
€111.31 Million
≈ $130.14 Million
0.207x +10.53%
2013-12-31 €481.84 Million
≈ $563.32 Million
€90.11 Million
≈ $105.34 Million
0.187x +66.16%
2012-12-31 €434.72 Million
≈ $508.24 Million
€48.93 Million
≈ $57.20 Million
0.113x -26.52%
2011-12-31 €395.63 Million
≈ $462.53 Million
€60.59 Million
≈ $70.84 Million
0.153x -23.15%
2010-12-31 €365.07 Million
≈ $426.80 Million
€72.76 Million
≈ $85.06 Million
0.199x -14.69%
2009-12-31 €393.20 Million
≈ $459.69 Million
€91.86 Million
≈ $107.39 Million
0.234x +83.84%
2008-12-31 €371.65 Million
≈ $434.49 Million
€47.23 Million
≈ $55.21 Million
0.127x +77.15%
2007-12-31 €362.76 Million
≈ $424.10 Million
€26.02 Million
≈ $30.42 Million
0.072x -76.57%
2006-12-31 €168.93 Million
≈ $197.50 Million
€51.72 Million
≈ $60.46 Million
0.306x +3.56%
2005-12-31 €148.35 Million
≈ $173.44 Million
€43.85 Million
≈ $51.27 Million
0.296x --

About Sartorius Stedim Biotech SA

PA:DIM France Medical Instruments & Supplies
Market Cap
$20.07 Billion
€17.17 Billion EUR
Market Cap Rank
#1550 Global
#35 in France
Share Price
€176.50
Change (1 day)
+0.06%
52-Week Range
€151.50 - €223.00
All Time High
€542.33
About

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more